Literature DB >> 7690794

HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.

A Sette1, J Sidney, C Oseroff, M F del Guercio, S Southwood, T Arrhenius, M F Powell, S M Colón, F C Gaeta, H M Grey.   

Abstract

In the present study, we describe the definition of a DRB1*0401 (DR4w4)-specific motif. The strategy used entailed a three-step process: 1) screening a large set of unrelated peptide ligands to identify good MHC binders; 2) truncation analysis of several DR4w4 binding peptides of high affinity to identify the crucial core-binding regions; 3) the use of single amino acid substitutions of the DR4w4-binding peptide hemagglutinin (HA) 307-319 to elucidate the specific residues crucial for binding. The DR4w4 motif is characterized by the presence of a hydrophobic or aromatic (F, W, Y, L, I, V, M) anchor residue in position 1, and a second hydroxyl (S, T) or aliphatic (L, I, V, or M) anchor residue in position 6. Furthermore, positive charges (R, K) are not allowed in positions 4, 7, and 9, and negative charges (D, E) are not allowed in position 9. This motif was present in 92% of good (IC50 < or = 100 nM) DR4w4-binding peptides, but less than 25% of the negative (IC50 > 45 microM) binders, indicating that the presence of the motif is necessary, but not sufficient for good DR4w4 binding capacity. The results of the present study are discussed in relation to previous work defining binding motifs and rules for other DR alleles, illustrating how different DR alleles bind variations on a similar structural theme. Finally, using two different peptide ligands [tetanus toxoid 830-843 and HA 307-319] as model systems, it is demonstrated how the fine allelic specificity of the DR binders can be predictably modulated by introducing subtle changes in the primary amino acid sequence.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690794

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Hindering auxiliary anchors are potent modulators of peptide binding and selection by I-Ak class II molecules.

Authors:  R R Latek; S J Petzold; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  Ligand design by a combinatorial approach based on modeling and experiment: application to HLA-DR4.

Authors:  Erik Evensen; Diane Joseph-McCarthy; Gregory A Weiss; Stuart L Schreiber; Martin Karplus
Journal:  J Comput Aided Mol Des       Date:  2007-07-27       Impact factor: 3.686

3.  Definition of the peptide binding motif within DRB1*1401 restricted epitopes by peptide competition and structural modeling.

Authors:  Eddie A James; Antonis K Moustakas; Deanna Berger; Laurie Huston; George K Papadopoulos; William W Kwok
Journal:  Mol Immunol       Date:  2008-02-13       Impact factor: 4.407

4.  Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen.

Authors:  C E Contreras; I N Ploton; R F Siliciano; C L Karp; R Viscidi; N Kumar
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

5.  Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.

Authors:  B S Nepom; G T Nepom; M Coleman; W W Kwok
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

6.  Analysis of peptide-binding motifs for two disease associated HLA-DR13 alleles using an M13 phage display library.

Authors:  M P Davenport; C L Quinn; P Valsasnini; F Sinigaglia; A V Hill; J I Bell
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

Review 7.  Drug delivery issues in vaccine development.

Authors:  M F Powell
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

8.  PRBAM: a new tool to analyze the MHC class I and HLA-DR anchor motifs.

Authors:  Anna Mestre-Ferrer; Erika Scholz; Jepi Humet-Alsius; Iñaki Alvarez
Journal:  Immunology       Date:  2018-11-22       Impact factor: 7.397

9.  Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Authors:  John Sidney; Scott Southwood; Carrie Moore; Carla Oseroff; Clemencia Pinilla; Howard M Grey; Alessandro Sette
Journal:  Curr Protoc Immunol       Date:  2013-02

10.  Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules.

Authors:  T P Astill; R J Ellis; S Arif; T I M Tree; M Peakman
Journal:  Diabetologia       Date:  2003-04-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.